Ventyx Sets Special Meeting for Lilly Merger Vote

summarizeSummary

Ventyx Biosciences has filed a preliminary proxy statement regarding the upcoming special meeting for shareholders to vote on the proposed merger with Eli Lilly. The board recommends voting in favor of the merger, which would result in shareholders receiving $14.00 per share.

check_boxKey Events

• Special Meeting Scheduled

  Ventyx sets date for special meeting to vote on merger with Eli Lilly.

• Merger Consideration Highlighted

  Shareholders to receive $14.00 per share in cash upon completion of the merger.

• Board Recommends Approval

  Ventyx's Board of Directors recommends shareholders vote in favor of the merger agreement.

• Appraisal Rights Available

  Stockholders have the right to seek appraisal of their shares under Delaware law.

auto_awesomeAnalysis

Ventyx Biosciences has scheduled a special meeting for shareholders to vote on the proposed merger with Eli Lilly. The proxy statement outlines the background, terms, and implications of the merger, including the recommendation from Ventyx's Board to vote in favor. This is important for investors to understand their rights and options regarding the merger.